Effectiveness of Khat on Eyelid Wound Healing After Oculoplastic Surgery - a Prospective Study.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03917641|
Recruitment Status : Unknown
Verified April 2019 by Sheba Medical Center.
Recruitment status was: Not yet recruiting
First Posted : April 17, 2019
Last Update Posted : April 17, 2019
|Condition or disease||Intervention/treatment||Phase|
|Hematoma Surgical Wound Surgery Eye Bruise Edema||Biological: Khat leaves||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||10 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Each participant is his own control|
|Masking:||None (Open Label)|
|Official Title:||Effectiveness of Khat on Eyelid Wound Healing After Oculoplastic Surgery - a Prospective Study.|
|Estimated Study Start Date :||July 1, 2019|
|Estimated Primary Completion Date :||July 1, 2020|
|Estimated Study Completion Date :||July 1, 2021|
Experimental: Patients after Oculoplastic surgery
Each participant will use one compression with Khat leaves and another standard compression and will decide on which eye to use which compression.
The compressions will be used for 10 minutes per every waking hour in the first 2 days post-op.
The patient will take pictures of both his eyes in days 1,3 and 7 post operative days.
Biological: Khat leaves
One of the two compressions (one per each eye) the patient will use will contain the Khat leaves.
- Edema [ Time Frame: 7 days post op ]Improvement in edema in the Khat compression in comparison to standard compression by clinical evaluation.
- Hematoma [ Time Frame: 7 days post op ]Improvement in hematomas in the Khat compression in comparison to standard by compression by clinical evaluation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03917641
|Contact: Guy J Ben Simon, MDfirstname.lastname@example.org|
|Ramat Gan, Israel, 52621|